InvestorsHub Logo
Followers 0
Posts 484
Boards Moderated 0
Alias Born 10/10/2014

Re: None

Monday, 02/13/2017 3:50:19 PM

Monday, February 13, 2017 3:50:19 PM

Post# of 2099
Good to hear confirmation on upcoming events:

1Q17 - Full Ph2 data of VB-111 in Thyroid Cancer
2H17 - Phase 3 Pivotal study in rGBM interim analysis
2H17 - Operation of new manufacturing facility
2H17 - Launch of Ph3 trial in Ovarian Cancer

Setting the stage nicely for the March conference call.

I liked his emphasis that VB-111 improves OS in late stage solid tumors in all comers (rGBM, ovarian, thyroid ... and lung).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBLT News